Asparaginase use for the treatment of acute lymphoblastic leukemia
Med Clin (Barc). 2017 Mar 3;148(5):225-231.
doi: 10.1016/j.medcli.2016.12.006.
Epub 2017 Jan 22.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Hematología, Hospital Universitari Vall d'Hebrón, Universidad Autònoma de Barcelona, Barcelona, España. Electronic address: [email protected].
- 2 Servicio de Oncología y Hematología pediátricas, Hospital Universitari Vall d'Hebrón, Barcelona, España.
- 3 Hospital Universitari i Politècnic la Fe, València, España.
- 4 Hospital Universitari Sant Joan de Déu, Barcelona, España.
No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Asparaginase / adverse effects
-
Asparaginase / therapeutic use*
-
Drug Administration Schedule
-
Drug Monitoring
-
Humans
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Asparaginase